Veeva: eTMF software makes CROs stand out from the cloud

By Dan Stanton

- Last updated on GMT

Veeva: eTMF software makes CROs stand out from the cloud

Related tags Clinical trial

Veeva Systems’ cloud-based software could be a decisive factor for pharma firms looking to select a CRO, the firm says as it reports a robust Q1.

For the first quarter of fiscal year 2016, the firm - which provides cloud-based software for R&D and commercial applications - reported revenues of $90m (€82m), up 35% year-on-year, while net income grew 80% to $13m.

The firm is advancing its position in the electronic trial master file (eTMF) sector for managing clinical trial data winning a top 20 Pharma client for its Vault software in the qaurter, CEO Peter Gassner told investors last week.

“Five of the top 20 pharmas have [now] selected Vault eTMF to manage their clinical trials documents globally,”​ he said. “In total more than 50 life sciences organizations are moving to the Veeva Vault’s eTMF.”

Matt Wallach, Veeva’s President, added the software was emerging as the industry standard for eTMF and would become a decisive factor for contract research organisations (CROs) looking to win pharma clients.

“When CROs are competing for a big deal at a pharma company, the pharma companies are now asking ‘what is your level of experience with Vault’ and that is helping to drive some of the discussions we’re having with the CROs.

There are two things going on​,” he continued: “The CROs that are using Vault today are having a lot of success and they are expanding their usage, and the usage within the sponsors is driving incremental interest within the other CROs that are not yet using it.”

However, according to a survey Veeva put out last year​ CROs were more likely than pharma firms to use paper documents across all functional areas, though around 20% use an eTMF application compared to 15% of sponsors.

Commercial GSK deal

Veeva also attributed its robust results to a number of other contract wins, including being selected by Big Pharma firm GlaxoSmithKline which entered a multi-year contract for multichannel customer relationship management (CRM) software, used to manage its customers’ engagement.

“GSK selected Veeva to be their global multichannel CRM partner and is expected to rollout globally over the next few years,”​ Gassner said last week.

“Having one of the leading pharma select us not only for our core CRM for face-to-face sales force automation, but at the same time make a commitment to multichannel is a big move.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Related suppliers

Follow us


View more